December 25, 2014 7:39 AM ET

Biotechnology

Company Overview of EpiVax, Inc.

Executive Profile

Jeff Bluestone Ph.D., A.W.

Consultant and Member of Scientific Advisory Board, EpiVax, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships
----

Background

Mr. Jeffrey A. Bluestone, Jeff, PhD., MD, AW, UCSF serves as a Mary Margaret Clausen Distinguished Professor of Medicine, Pathology, Microbiology & Immunology at the University of California, San Francisco (UCSF). Mr. Bluestone serves as a Consultant at EpiVax, Inc. He is an expert in diabetes and immunology. He serves as Member of Scientific Advisory Board of ViaCyte, Inc. (formerly Novocell, Inc.), EpiVax, Inc., Trubion Pharmaceuticals Inc. and XDx, Inc. He serves ...

Corporate Headquarters

146 Clifford Street
Providence, Rhode Island 02903

United States

Phone: 401-272-2123
Fax: 401-272-7562

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EpiVax, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.